Summary
Intra-articular corticosteroid injections are widely used in aseptic arthritis, most often as a supplement to systemic anti-inflammatory therapy. Suppression of local joint inflammation by corticosteroids is rapid and pronounced, and may be achieved with only minor systemic effects; however, this suppression is usually only temporary. The original compound hydrocortisone acetate has been replaced by longer-acting preparations such as methylprednisolone acetate, tri-amcinolone acetonide and triamcinolone hexacetonide. In controlled studies, triamcinolone hexacetonide has proved most effective, providing clinical effect for a mean period up to several months. However, this compound frequently causes local tissue necrosis when injected outside a synovial cavity, and it should be used only by experienced clinicians.
Indications for intra-articular corticosteroids include mono- or oligoarthritis in rheumatoid arthritis and other aseptic inflammatory joint diseases. Intra-articular corticosteroids are also used in osteoarthritis, but in controlled studies the effect is brief and transient.
A number of potential adverse effects of intra-articular corticosteroids stress the importance of their judicious use. The risk of cartilage damage and progressive joint destruction is a controversial issue. The results of animal studies are ambiguous. Despite case reports of severe arthropathy, most studies on humans suggest that, when used appropriately, the beneficial effects of intra-articular corticosteroids exceed the harmful effects. Nevertheless, it is recommended that corticosteroid injections into the same joint should be limited, for instance to 1 injection every 6 weeks and no more than 3 to 4 in 1 year. Prior to intra-articular corticosteroid injections the indications and contraindications should always be considered. In particular, infection should be ruled out. Strict aseptic technique is essential to avoid iatrogenic septic arthritis.
Correct intra-articular corticosteroid therapy is of great clinical value in the management of aseptic arthritic disease.
Similar content being viewed by others
References
Hollander JL, Brown EMJ, Jessar RA. Hydrocortisone and cortisone injected into arthritic joints: comparative effects of and use of hydrocortisone as a local antiarthritic agent. JAMA 1951; 147: 1629–35
Brown EMJ, Frain JB. Locally administered hydrocortisone in the rheumatic diseases: a summary of its use in 547 patients. Am J Med 1953; 15: 656–65
Ziff M, Scull E, Ford D, et al. Effects in rheumatoid arthritis of hydrocortisone and cortisone injected intra-articularly. AMA Arch Int Med 1952; 90: 774–84
Kendall H. Triamcinolone hexacetonide: a new corticosteroid for intra-articular therapy. Ann Phys Med 1967; 9: 55–8
Blyth T, Hunter JA, Stirling A. Pain relief in the rheumatoid knee after steroid injection: a single-blind comparison of hydrocortisone succinate and triamcinolone acetonide or hexacetonide. Br J Rheumatol 1994; 33: 461–3
Anttinen J, Oka M. Intra-articular triamcinolone hexacetonide and osmic acid in persistent synovitis of the knee. Scand J Rheumatol 1975; 4: 125–8
Emery P. The optimal management of early rheumatoid disease: the key to preventing disability. Br J Rheumatol 1994; 8: 765–8
Emery P. Early rheumatoid arthritis: therapeutic strategies. Scand J Rheumatol 1994; Suppl. 100: 3–7
Dawes PT, Fowler PD. Treatment of early rheumatoid arthritis: a review of current and future concepts and therapy. Clin Exp Rheumatol 1995; 13: 381–94
Jaffe IA. New approaches to the management of rheumatoid arthritis. J Rheumatol 1992; 19Suppl. 36: 2–8
Semble EL. Rheumatoid arthritis: new approaches for its evaluation and management. Arch Phys Med Rehabil 1995; 76: 190–201
American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 1996; 39: 713–22
Kelley WN, Harris ED, Ruddy S, et al., editors. Textbook of rheumatology. 4th ed. Philadelphia: W.B. Saunders, 1993
Klippel JH, Dieppe PA, editors. Rheumatology. London: Mosby Year Book Europe Limited, 1994
McCarty DJ, editor. Arthritis and allied conditions: a textbook of rheumatology. 11th ed. Philadelphia: Lea & Febiger, 1989
Eymontt MJ, Gordon GV, Schumacher HR, et al. The effects on synovial permeability and synovial fluid leukocyte counts in symptomatic osteoarthritis after intra-articular corticosteroid administration. J Rheumatol 1982; 9: 198–203
Østergaard M, Stoltenberg M, Henriksen O, et al. Quantitative assessment of synovial inflammation by dynamic gadolinium-enhanced MRI: a study of the effect of intra-articular methylprednisolone on the rate of early synovial enhancement. Br J Rheumatol 1996; 35: 50–9
de Bois MHW, Arndt JW, Tak PP, et al. 99 Tcm -labelled polyclonal human immunoglobulin G scintigraphy before and after intra-articular knee injection of triamcinolone hexacetonide in patients with rheumatoid arthritis. Nucl Med Commun 1993; 14: 883–7
McCarty DJ. Treatment of rheumatoid joint inflammation with triamcinolone hexacetonide. Arthritis Rheum 1972; 15: 157–73
Dixon ASJ, Bywaters EGL. The effect of intra-articular injection of cortisone acetate and of hydrocortisone acetate in rheumatoid arthritis. Clin Sci 1953; 12: 15–31
Lupetin AR, Daffner RH. Rheumatoid iliopsoas bursitis: MR findings. J Comput Assist Tomogr 1990; 14: 1035–6
Esselinckx W, Bacon PA, Ring EFJ, et al. A thermographic assessment of three intra-articular prednisolone analogues given in rheumatoid synovitis. Br J Clin Pharmacol 1978; 5: 447–51
Wingstrand H, Egund N, Forsberg L. Sonography and joint pressure in synovitis of the adult hip. J Bone Joint Surg 1987; 69-B: 254–6
Bird HA, Ring EFJ, Daniel R, et al. Comparison of intra-articular methotrexate with intra-articular triamcinolone hexacetonide by thermography. Curr Med Res Opin 1977; 5: 141–6
Østergaard M, Stoltenberg M, Gideon P, et al. Changes in synovial membrane and joint effusion volumes following intra-articular methylprednisolone: quantitative assessment of inflammatory and destructive changes in rheumatoid arthritis by MRI. J Rheumatol 1996; 23: 1151–61
Dixon ASJ, Graber J. Local injection therapy in rheumatic disease. Dürrigl T, editor. Basle: Eular Publishers, 1981: 1–175
Fernandez-Madrid F, Karvonen RL, Teitge RA, et al. Synovial thickening detected by MR imaging in osteoarthritis of the knee confirmed by biopsy as synovitis. Magn Resonance Imaging 1995; 13: 177–83
Hochberg MC, Altaian RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. Arthritis Rheum 1995; 38: 1541–6
Dieppe PA, Sathapatayavongs B, Jones HE, et al. Intra-articular steroids in osteoarthritis. Rheumatol Rehabil 1980; 19: 212–7
Friedman DM, Moore ME. The efficacy of intra-articular steroids in osteoarthritis: a double-blind study. J Rheumatol 1980; 7: 850–6
Hochberg MC, Altaian RD, Brandt KD, et al. Guidelines for medical management of osteoarthritis. Part I. Osteoarthritis of the hip. Arthritis Rheum 1995; 38: 1535–40
Centeno LM, Moore ME. Preferred intra-articular corticosteroids and associated practice: a survey of members of the American College of Rheumatology. Arthritis Care Res 1994; 7: 151–5
Chandler GN, Wright V, Hartfall SJ. Intra-articular therapy in rheumatoid arthritis: comparison of hydrocortisone tertiary butyl acetate and hydrocortisone acetate. Lancet 1958; II: 659–61
Bird HA, Ring EFJ, Bacon PA. A thermographic and clinical comparison of three intra-articular steroid preparations in rheumatoid arthritis. Ann Rheum Dis 1979; 38: 36–9
Hollander JL. Intra-synovial corticosteroid therapy in rheumatoid arthritis. Md State Med J 1970; 19: 62–6
Chakravarty K, Pharoah PDP, Scott GI. A randomized controlled study of post-injection rest following intra-articular therapy for knee synovitis. Br J Rheumatol 1994; 33: 464–8
Chatham W, Williams G, Moreland L, et al. Intra-articular corticosteroid injections: should we rest the joints. Arthritis Care Res 1989; 2: 70–4
Hollander JL, Jessar RA, Brown EMJ. Intra-synovial corticosteroid therapy: a decade of use. Bull Rheum Dis 1961; 11: 239–40
Gray RG, Tenenbaum J, Gottlieb N. Local corticosteroid injection treatment in rheumatic disorders. Semin Arthritis Rheum 1981; 10: 231–54
Berger RG, Yount WJ. Immediate ’steroid flare’ from intra-articular triamcinolone hexacetonide injection: case report and review of the literature. Arthritis Rheum 1990; 33: 1284–6
Kendall H. Local corticosteroid injection therapy. III. Ann Phys Med 1963; 7: 31–8
Mahler F, Fritschy D. Partial and complete ruptures of achilles tendon and local corticosteroid injections. Br J Sports Med 1992; 26: 7–14
Alexeef M. Ligamentum patellae rupture following local steroid injection. Aust NZ J Surg 1986; 56: 681–3
Friedman SJ, Butler DF, Pittelkow MR. Perilesional linear atrophy and hypopigmentation after intralesional corticosteroid therapy: report of two cases and review of the literature. J Am Acad Dermatol 1988; 19: 537–41
Gottlieb NL, Riskin WG. Complications of local corticosteroid injections. JAMA 1980; 243: 1547–8
Cassidy J, Bole GG. Cutaneous atrophy secondary to intra-articular corticosteroid administration. Ann Intern Med 1966; 65: 1008–18
Gilsanz V, Bernstein BH. Joint calcification following intra-articular corticosteroid therapy. Radiology 1984; 151: 647–9
Bijlsma JWJ, van Everdingen AA, Jacobs JWG. Corticosteroids in rheumatoid arthritis: how best to use them? Clin Immunother 1995; 3: 271–86
Ward LE, Mason HL. Systemic effects from hydrocortisone acetate administered intra-articularly to rheumatoid patients. J Clin Lab Med 1953; 42: 961–2
Koehler BE, Urowitz MB, Killinger DW. The systemic effects of intra-articular corticosteroid. J Rheumatol 1974; 1: 117–25
Cunningham GR, Goldzieher JW, de la Pena A, et al. The mechanism of ovulation inhibition by triamcinolone acetonide. J Clin Endocrinol Metab 1978; 46: 8–14
Mankin HJ, Conger KA. The acute effects of intra-articular hydrocortisone on articular cartilage in rabbits. J Bone Joint Surg 1966; 48A: 1383–8
Behrens F, Shepard N, Mitchell N. Alteration of rabbit articular cartilage by intra-articular injections of glucocorticoids. J Bone Joint Surg 1975; 57A: 70–6
Moskowitz RW, Davis W, Sammarco J, et al. Experimentally induced corticosteroid arthropathy. Arthritis Rheum 1970; 13: 236–43
Pelletier JP, Mineau F, Raynauld JP, et al. Intra-articular injections with methylprednisolone acetate reduce osteoarthritic lesions in parallel with chondrocyte stromelysin synthesis in experimental osteoarthritis. Arthritis Rheum 1994; 37: 414–23
Pelletier JP, Martel-Pelletier J. In vivo protective effects of prophylactic treatment with tiaprofenic acid or intra-articular corticosteroids on osteoarthritic lesions in the experimental dog model. J Rheumatol Suppl 1991; 18Suppl. 27: 127–30
Pelletier JP, DiBattista JA, Raynauld JP, et al. The in vivo effects of intra-articular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1, and oncogene protein synthesis in experimental osteoarthritis. J Lab Invest 1995; 72: 578–86
Williams JM, Brandt KD. Triamcinolone hexacetonide protects against fibrillation and osteophyte formation following chemically induced articular cartilage damage. Arthritis Rheum 1985; 28: 1267–74
Chandler GN, Wright V. Deleterious effect of intra-articular hydrocortisone. Lancet 1958; II: 661–3
Bentley G, Goodfellow JW. Disorganisation of the knees following intra-articular hydrocortisone injections. J Bone Joint Surg 1969; 51B: 498–502
Sweetnam DR, Mason RM, Murray RO. Steroid arthropathy of the hip. BMJ 1960 May 7; 1: 1392–4
Laroche M, Arlet J, Mazieres B. Osteonecrosis of the femoral and humeral heads after intra-articular corticosteroid injections. J Rheumatol 1990; 17: 549–51
Parikh JR, Houpt JB, Jacobs S, et al. Charcot’s arthropathy of the shoulder following intra-articular corticosteroid injections. J Rheumatol 1993; 20: 885–7
McCarty DJ, McCarthy G, Carrera G. Intra-articular corticosteroids possibly leading to local osteonecrosis and marrow fat induced synovitis. J Rheumatol 1991; 18: 1091–4
Balch HW, Gibson JM, El Ghobarey AF, et al. Repeated corticosteroid injections into knee joints. Rheumatol Rehabil 1977; 16: 137–40
Wada J, Koshino T, Morii T, et al. Natural course of osteoarthritis of the knee treated with or without intra-articular corticosteroid injections. Bull Hosp Jt Dis 1993; 53: 45–8
Sparling M, Malleson P, Petty R. Radiographic followup of joints injected with triamcinolone hexacetonide for the management of childhood arthritis. Arthritis Rheum 1990; 33: 821–6
Kaplan H. Therapeutic injection of joints and soft tissues. In: Schumacher HR, Klippel JH, Koopman WJ, editors. Primer on the rheumatic diseases. 10th ed. Atlanta: Arthritis Foundation, 1993; 58: 310–1
Hasselbacher P. Arthrocentesis, synovial fluid analysis, and synovial biopsy. In: Schumacher HR, Klippel JH, Koopman WJ, editors. Primer on the rheumatic diseases. 10th ed. Atlanta: Arthritis Foundation, 1993; 8C: 67–72.67
Gumpel JM, Roles NC. A controlled trial of intra-articular radiocolloids versus surgical synovectomy in persistent synovitis. Lancet 1975; II: 488–9
Onetti CM, Gutiérrez E, Hliba E, et al. Synoviorthesis with 32 P-colloidal chromic phosphate in rheumatoid arthritis — clinical, histopathological and arthrographic changes. J Rheumatol 1982; 9: 229–38
Sheppeard H, Aldin A, Ward DJ. Osmic acid versus yttrium-90 in rheumatoid synovitis of the knee. Scand JRheumatol 1981; 10: 234–6
Gumbel JM, Matthews SA, Fisher M. Synoviorthesis with erbium-169: a double-blind controlled comparison with corticosteroid. Ann Rheum Dis 1979; 38: 341–3
Nissilä M, Anttila P, Hämäläinen M, et al. Comparison of chemical, radiation and surgical synovectomy for knee joint synovitis. Scand J Rheumatol 1978; 7: 225–8
Sheppeard H, Ward D. Intra-articular osmic acid in rheumatoid arthritis: five years’ experience. Rheumatol Rehabil 1980; 19: 25–9
Martio J, Isomäki H, Heikkola T, et al. The effect of intra-articular osmic acid in juvenile rheumatoid arthritis. Scand J Rheumatol 1972; 1: 5–8
Østergaard M, Stoltenberg M, Gideon P, et al. Effect of intra-articular osmic acid on synovial membrane volume and inflammation, determined by magnetic resonance imaging. Scand J Rheumatol 1995; 24: 5–12
Rylance HJ, Chalmers TM. Clinical trials of intra-articular aspirin in rheumatoid arthritis. Lancet 1980; II: 1099–102
Goebel K-M, Storck U, Neurath F. Intrasynovial orgotein therapy in rheumatoid arthritis. Lancet 1981; I: 1015–7
Mazieres B, Masquelier AM, Capron MH. A French controlled multicenter study of intra-articular orgotein versus intra-articular corticosteroids in the treatment of knee osteoarthritis: a one-year followup. J Rheumatol 1991; 18Suppl. 27: 134–7
Dingle JT, Gordon JL, Hazleman BL, et al. Novel treatment for joint inflammation. Nature 1978; 271: 372–3
Rosner IA, Goldberg VM, Getzy L, et al. A trial of intra-articular orgotein, a Superoxide dismutase, in experimentally-induced osteoarthritis. J Rheumatol 1980; 7: 24–9
de Silva M, Hazleman BL, Thomas DPP, et al. Liposomes in arthritis: a new approach. Lancet 1979; I: 1320–2
Combe B, Krause E, Sany J. Treatment of chronic knee synovitis with arthroscopic synovectomy after failure of intra-articular injection of radionuclide. Arthritis Rheum 1989; 32: 10–4
Ogilvie-Harris DJ, Basinski A. Arthroscopic synovectomy of the knee for rheumatoid arthritis. Arthroscopy 1991; 7: 91–7
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Østergaard, M., Halberg, P. Intra-Articular Corticosteroids in Arthritic Disease. BioDrugs 9, 95–103 (1998). https://doi.org/10.2165/00063030-199809020-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00063030-199809020-00002